Evotec SE EVO
NASDAQ EVO
$1.81 -0.01 (-0.55%)
At close: Sep 9, 2026 · 4:00 PM EDT

Evotec SE (EVO) Operating Margin Growth (1y) (2010 - 2025)

Analysis

Evotec SE (EVO) Operating Margin Growth (1y) (2010 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Iqvia Holdings 42.77 Bn 40.69 Bn 1.44 Bn -101.00
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn -18.00
3 Charles River Laboratories International 13.37 Bn 13.18 Bn 452.07 Mn 224.00
4 Icon 12.49 Bn 11.56 Bn 479.29 Mn -465.00
5 Fortrea Holdings 1.58 Bn 1.42 Bn 139.20 Mn 4,868.00
6 Evotec SE 642.83 Mn 216.96 Mn - -
7 Ginkgo Bioworks Holdings 422.55 Mn 338.02 Mn 18.44 Mn -14,185.00
8 Champions Oncology 69.16 Mn 69.16 Mn 7.03 Mn 1,247.00
9 MindWalk Holdings 59.83 Mn 51.55 Mn 1.82 Mn 14,635.00
10 VivoSim Labs 1.45 Mn 1.45 Mn - -744,940.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1,239.00
Sep 30, 2025 -1,283.00
Jun 30, 2025 -6,643.00
Mar 31, 2025 -128.00
Dec 31, 2024 620,132.00
Jun 30, 2024 6,720.00
Dec 31, 2023 -619,550.00
Jun 30, 2023 -1,480.00
Dec 31, 2022 -993.00
Sep 30, 2022 -1.11 Mn
Jun 30, 2022 -330.00
Mar 31, 2022 -481,182.00
Dec 31, 2021 -305.00
Sep 30, 2021 -153,769.00
Dec 31, 2020 -545.00
Jun 30, 2010 9,645.00
Mar 31, 2010 -26,078.00